FDA unveils a priority voucher program to accelerate drug reviews for national priorities, using a team-based review model.

Sage Therapeutics shares gained 0.4% to trade at $9.11 on Tuesday. These analysts made changes to their price targets on Sage ...

Lenacapavir, a twice-yearly HIV prevention shot by Gilead, could be produced for $25 a year but may sell for $25K, raising ...

Wedbush Fund Advisers CIO Cullen Rogers tells Benzinga: "We don't react to short-term performance or headlines." ...

Jabil Inc. JBL reported better-than-expected third-quarter results on Tuesday. The company reported quarterly adjusted ...

Shares of Digital Turbine Inc. (NASDAQ: APPS) are trading higher Tuesday after the company released its fourth-quarter ...

Vertiv Holdings Co (NYSE:VRT) is booming in the AI industry with a deal with Nvidia and an analyst upgrade, making it a ...

Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems.

Whales with a lot of money to spend have taken a noticeably bearish stance on Arista Networks. If we consider the specifics of each trade, it is accurate to state that 33% of the investors opened ...

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $55.0 to $195.0 for Micron Technol ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $450.0 to $1750.0 for Netflix over the last 3 months.

A former Bank of England economist is raising red flags over the growing role of stablecoins in the U.S. financial system, ...